Blog

Dec 16, 2024, 17:18

Rahul Banerjee: Antibody targets in smoldering multiple myeloma analyzed

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X:

“Fascinating analysis in HemaSphere Journal by Hermouet Sigurdur Kristinsson et al. – what is the antibody in smoldering multiple myeloma?

Unknown in a third of cases, but often targeting infection. A fascinating what-if question in the concluding paragraph below pertinent to all plasma cell disorders.”

Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.

He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.

antibody targets cancer Hemasphere EHA hematologic malignancies hematology research Hermouet infection triggers multiple myeloma OncoDaily Oncology oncology research plasma cell disorders Rahul Banerjee Sigurdur Kristinsson Smoldering multiple myeloma Sykristinsson

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage